ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries"
Episode Synopsis
0:53 Jason intros Sajith Wickramasekara
1:40 What does Benchling do?
2:24 How did Sajith get into life science?
6:55 Benchling's value proposition for scientists
9:04 How do they charge?
10:43 Is Chamath Palihapitiya the most famous Sri Lankan in the US?
13:25 Why immunotherapy is the most exciting development in life science
19:00 3D Printing & harvesting organs in other species
20:50 Ethics of editing a human embryo
28:19 How did the scientific community respond to the embryo controversy
29:52 Breakthroughs in gene therapy
34:09 Defining the line between quackery & brilliance
42:37 Upside & downside of genetically modified crops
47:54 What is the best approach for breakthroughs in life science?
1:40 What does Benchling do?
2:24 How did Sajith get into life science?
6:55 Benchling's value proposition for scientists
9:04 How do they charge?
10:43 Is Chamath Palihapitiya the most famous Sri Lankan in the US?
13:25 Why immunotherapy is the most exciting development in life science
19:00 3D Printing & harvesting organs in other species
20:50 Ethics of editing a human embryo
28:19 How did the scientific community respond to the embryo controversy
29:52 Breakthroughs in gene therapy
34:09 Defining the line between quackery & brilliance
42:37 Upside & downside of genetically modified crops
47:54 What is the best approach for breakthroughs in life science?
More episodes of the podcast This Week in Startups
Sending datacenters into orbit | E2203
03/11/2025
Jason Unpacks Sequoia’s New Funds | E2199
28/10/2025
In God we trust